Literature DB >> 2087299

Role of staphylococcal toxin production in blepharitis.

D Seal1, L Ficker, M Ramakrishnan, P Wright.   

Abstract

Lid isolates of Staphylococcus aureus and coagulase-negative staphylococci (CNS) from controls (12 S. aureus and 110 CNS) and from patients with blepharitis (17 S. aureus and 171 CNS) were tested for production of alpha, beta, delta, epsilon, and previously undescribed hemolytic toxins, because toxin production has been implicated as a cause of blepharoconjunctivitis. The electrolyte content of agar media required for toxin production was first investigated. Alpha-lysin was found to be produced by all isolates of S. aureus colonizing lids of normal controls and patients with blepharitis, but by none of 281 CNS isolates. A new toxin was identified, having low molecular weight (5 kd), produced by one CNS strain isolated from a blepharitic lid. It was produced on basic nutrient agar that lacked sodium but contained glucose, which inhibited production of alpha-lysin. It hemolyzed rabbit and sheep erythrocytes and, surprisingly, was neutralized by polyclonal antiserum to alpha-lysin. This may explain occasional reports of alpha-lysin production by CNS. The overall results do not support a hypothesis of hemolytic toxin production by staphylococci as a general cause of blepharitis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2087299     DOI: 10.1016/s0161-6420(90)32361-8

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  6 in total

1.  Immunization with alpha-toxin toxoid protects the cornea against tissue damage during experimental Staphylococcus aureus keratitis.

Authors:  E B Hume; J J Dajcs; J M Moreau; R J O'Callaghan
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

Review 2.  Interventions for chronic blepharitis.

Authors:  Kristina Lindsley; Sueko Matsumura; Elham Hatef; Esen K Akpek
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

3.  Acute systemic immune activation following conjunctival exposure to staphylococcal enterotoxin B.

Authors:  Govindarajan Rajagopalan; Michele K Smart; Robin Patel; Chella S David
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

4.  A prospective study determining the efficacy of topical 0.5% levofloxacin on bacterial flora of patients with chronic blepharoconjunctivitis.

Authors:  Yazmin Yactayo-Miranda; Christopher N Ta; Lisa He; Thomas C Kreutzer; Martin M Nentwich; Anselm Kampik; Herminia Mino de Kaspar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-02-11       Impact factor: 3.117

5.  A European perspective on topical ophthalmic antibiotics: current and evolving options.

Authors:  D Bremond-Gignac; F Chiambaretta; S Milazzo
Journal:  Ophthalmol Eye Dis       Date:  2011-10-24

6.  Topical cyclosporin as an alternative treatment for vision threatening blepharokeratoconjunctivitis: a case report.

Authors:  Abdul-Salim Ismail; Rohana Taharin; Zunaina Embong
Journal:  Int Med Case Rep J       Date:  2012-06-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.